BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2704821)

  • 1. Chemical shift imaging with paramagnetic contrast material enhancement for improved lesion depiction.
    Simon JH; Szumowski J
    Radiology; 1989 May; 171(2):539-43. PubMed ID: 2704821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-DTPA enhancement of an optic nerve and chiasmal meningioma.
    Haik BG; Zimmerman R; Saint Louis L
    J Clin Neuroophthalmol; 1989 Jun; 9(2):122-5. PubMed ID: 2526157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.
    Dwyer AJ; Frank JA; Doppman JL; Oldfield EH; Hickey AM; Cutler GB; Loriaux DL; Schiable TF
    Radiology; 1987 May; 163(2):421-6. PubMed ID: 3562821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gd-DTPA enhanced high resolution MR imaging of pituitary adenomas.
    Steiner E; Imhof H; Knosp E
    Radiographics; 1989 Jul; 9(4):587-98. PubMed ID: 2756189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gadolinium-DTPA combined with a fat suppression technique in studies with magnetic resonance at 0.5 T in soft-tissue neoplasms].
    Battolla L; Zampa V; Mascalchi M; Falaschi F; Bagnolesi P; Tessa C; Paolicchi A; Bartolozzi C
    Radiol Med; 1994 Oct; 88(4):353-8. PubMed ID: 7997603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
    Giovagnoni A; Paci E
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
    Bradac GB; Riva A; Berger T; Stura G; Duca S
    Radiol Med; 1988; 76(1-2):33-7. PubMed ID: 3399707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE; Kneeland JB; Haughton VM; Daniels DL; Szumowski J; Williams AL; Mark LP; Czervionke LF
    AJR Am J Roentgenol; 1990 Oct; 155(4):849-54. PubMed ID: 2119121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
    Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
    AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-DTPA enhancement of VX-2 carcinoma of the rabbit kidney on T1 weighted magnetic resonance images.
    Yancey JM; Ackerman N; Kaude JV; Googe RE; Fitzsimmons JR; Scott KN; Mancuso AA; Hackett RL; Hager DA; Caballero S
    Acta Radiol; 1987; 28(4):479-82. PubMed ID: 2958067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B; Laniado M; Saini S
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gd-DTPA in the MR diagnosis of pituitary adenomas].
    Steiner E; Wimberger D; Imhof H; Knosp E; Hajek P
    Rofo; 1989 Mar; 150(3):323-7. PubMed ID: 2538883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
    Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
    Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of local soft tissue inflammation using gadolinium-DTPA.
    Paajanen H; Brasch RC; Schmiedl U; Ogan M
    Acta Radiol; 1987; 28(1):79-83. PubMed ID: 2952148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
    Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
    Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior].
    Doringer E; Joos H; Forstner R; Schmoller H
    Rofo; 1991 Apr; 154(4):357-63. PubMed ID: 1850149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign extraaxial tumors: contrast enhancement with Gd-DTPA.
    Breger RK; Papke RA; Pojunas KW; Haughton VM; Williams AL; Daniels DL
    Radiology; 1987 May; 163(2):427-9. PubMed ID: 3031727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.